Mechanisms of antifungal drug resistance in Candida dubliniensis.
AffiliationMicrobiology Research Unit, Division of Oral Biosciences, Dublin Dental School & Hospital, University of Dublin, Trinity College Dublin, Dublin 2, Republic of Ireland. firstname.lastname@example.org
Drug Resistance, Fungal
MetadataShow full item record
CitationMechanisms of antifungal drug resistance in Candida dubliniensis. 2010, 5 (6):935-49 Future Microbiol
AbstractCandida dubliniensis was first described in 1995 and is the most closely related species to the predominant human fungal pathogen Candida albicans. C. dubliniensis is significantly less prevalent and less pathogenic than C. albicans and is primarily associated with infections in HIV-infected individuals and other immunocompromised cohorts. The population structure of C. dubliniensis consists of three well-defined major clades and is significantly less diverse than C. albicans. The majority of C. dubliniensis isolates are susceptible to antifungal drugs commonly used to treat Candida infections. To date only two major patterns of antifungal drug resistance have been identified and the molecular mechanisms of these are very similar to the resistance mechanisms that have been described previously in C. albicans. However, significant differences are evident in the predominant antifungal drug mechanisms employed by C. dubliniensis, differences that reflect its more clonal nature, its lower prevalence and characteristics of its genome, the complete sequence of which has only recently been determined.
- Azole susceptibility and resistance in Candida dubliniensis.
- Authors: Pinjon E, Moran GP, Coleman DC, Sullivan DJ
- Issue date: 2005 Nov
- Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.
- Authors: Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, Coleman DC
- Issue date: 2004 Jan
- Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
- Authors: Chunchanur SK, Nadgir SD, Halesh LH, Patil BS, Kausar Y, Chandrasekhar MR
- Issue date: 2009 Oct-Dec
- Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.
- Authors: Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, Coleman DC
- Issue date: 1997 Mar
- Candida dubliniensis, a new fungal pathogen.
- Authors: Gutiérrez J, Morales P, González MA, Quindós G
- Issue date: 2002